The numbers of IL-17A+ cells and RANKL+ cells were increased, and significantly higher in COPD compared with never-smoker subjects or smoker subjects without airway obstruction (P<0.05) (Figures 2J, K). Here, IL17A is linked to chronic obstructive pulmonary disease.